Medications which have clearly demonstrated tolerability and efficacy by the end of an appropriate trial period ought to be continued; medicines not achieving such standards should be stopped (or, if essential (such as with high doses of glucocorticoids),

Kafa, Jerek, Urkrass and Bernado Kyrgyzstan

zbntfyhi@duhastmail.com

86128439579

HamlarBlaro

2026-09-22 01:37:09

隐藏

返回